Suppr超能文献

阿片受体μ1 基因与帕金森病冲动控制障碍的相关性研究

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.

机构信息

Sorbonne Universités, UMR_S1127, ICM, F-75013, Paris, France.

INSERM, UMR_S1127, Paris, France.

出版信息

Mov Disord. 2018 Dec;33(12):1878-1886. doi: 10.1002/mds.27519. Epub 2018 Nov 16.

Abstract

BACKGROUND

Impulse control disorders are frequently associated with dopaminergic therapy in Parkinson's disease. Genetic studies have suggested a high heritability of impulse control disorders in the general population and in PD. The aim of this study was to identify candidate gene variants associated with impulse control disorders and related behaviors in PD.

METHODS

We performed a multicenter case-control study in PD patients with (cases) or without impulse control disorders and related behaviors despite significant dopamine agonist exposure of >300 mg levodopa-equivalent daily dose during 12 months (controls). Behavioral disorders were assessed using the Ardouin scale. We investigated 50 variants in 24 candidate genes by a multivariate logistic regression analysis adjusted for sex and age at PD onset.

RESULTS

The analysis was performed on 172 cases and 132 controls. Cases were younger (60 ± 8 vs 63 ± 8 years; P < 0.001) and had a higher family history of pathological gambling (12% vs 5%, P = 0.03). No variant was significantly associated with impulse control disorders or related behaviors after correction for multiple testing, although the 2 top variants were close to significant (OPRM1 rs179991, OR, 0.49; 95%CI, 0.32-0.76; P = 0.0013; Bonferroni adjusted P = 0.065; DAT1 40-base pair variable number tandem repeat, OR, 1.82; 95%CI, 1.24-2.68; P = 0.0021; Bonferroni adjusted P = 0.105).

CONCLUSIONS

Our results are suggestive of a novel association of the opioid receptor gene OPRM1 with impulse control disorders and related behaviors in PD and confirm a previous association with DAT1. Although replication in independent studies is needed, our results bring potential new insights to the understanding of molecular mechanisms of impulse control disorders. © 2018 International Parkinson and Movement Disorder Society.

摘要

背景

冲动控制障碍常与帕金森病的多巴胺能治疗相关。遗传研究表明,冲动控制障碍在普通人群和帕金森病患者中具有较高的遗传性。本研究旨在确定与帕金森病患者冲动控制障碍和相关行为相关的候选基因变异。

方法

我们对帕金森病患者进行了一项多中心病例对照研究,患者在 12 个月内接受了 >300mg 左旋多巴等效日剂量的多巴胺激动剂治疗,尽管有显著的多巴胺激动剂暴露,但仍出现了冲动控制障碍和相关行为(病例)或无冲动控制障碍和相关行为(对照)。使用 Ardouin 量表评估行为障碍。我们通过多元逻辑回归分析,对 24 个候选基因中的 50 个变异进行了研究,该分析调整了性别和帕金森病发病年龄。

结果

对 172 例病例和 132 例对照进行了分析。病例组更年轻(60±8 岁 vs 63±8 岁;P<0.001),且有更高的病理性赌博家族史(12% vs 5%;P=0.03)。尽管经过多重检验校正后,没有一个变异与冲动控制障碍或相关行为显著相关,但前 2 个变异接近显著(OPRM1 rs179991,OR,0.49;95%CI,0.32-0.76;P=0.0013;Bonferroni 校正后 P=0.065;DAT1 40 碱基对可变数串联重复,OR,1.82;95%CI,1.24-2.68;P=0.0021;Bonferroni 校正后 P=0.105)。

结论

我们的研究结果提示,阿片受体基因 OPRM1 与帕金森病患者的冲动控制障碍和相关行为之间存在新的关联,并证实了与 DAT1 的先前关联。尽管需要在独立研究中进行复制,但我们的研究结果为理解冲动控制障碍的分子机制提供了新的见解。 © 2018 国际帕金森病与运动障碍学会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验